Category Archives: The IPO Buzz

Arcellx (ACLX), a cancer-focused biotech, shot up to $19 at its opening trade on Friday (Feb. 4, 2022) – up $4 from its IPO price – in its NASDAQ debut. Arcellx priced its IPO on Thursday (Feb. 3, 2022) at $15 – the low end of its $15-to-$17 range – on 8.25 million shares. The […]

Credo Technology Group Holding, Ltd. (CRDO) slashed the number of shares in its IPO and priced the deal at $10 – the low end of its $10-to-$12 range – on Wednesday night (Jan. 26, 2022). The deal was cut to 20 million shares, down from 25 million in the prospectus, to raise $200 million – […]

Credo Technology Group Holding Ltd. (CRDO proposed), a semiconductor connectivity solutions provider, is the name to note as January 2022 enters its final week. Credo is the only large deal on this week’s IPO Calendar – in a market frozen by fear of rising interest rates ahead and inflation at a 40-year high. The NASDAQ […]

Postponed is the word of the day. Bitcoin miner Rhodium Enterprises, Inc. (RHDM proposed) and a REIT, Four Springs Capital Trust (FSPR proposed), have pulled their IPOs – both expected to start trading today (Thursday, Jan. 20, 2022) – “due to market conditions.” The NASDAQ’s slide into correction territory on Wednesday was the reason. “They […]

Japan, a Bitcoin miner and a real estate investment trust (REIT) are featured on this week’s IPO Calendar. But the U.S. stock market’s plunge on Tuesday drove the NASDAQ down close to correction territory as bond yields hit a two-year high. Tuesday’s sell-off was a shock after the long holiday weekend. The U.S. stock market […]

Private equity powerhouse TPG, Inc. (TPG) jumped 15.25 percent on Thursday (Jan. 13, 2022) in its NASDAQ debut – to close at $34, up $4.50 from its $29.50 IPO price – and you could almost catch the sweet scent of relief washing over Wall Street after a nerve-wracking week. TPG priced its IPO at the mid-point […]

Biotechs braved the chill winds of January to jump-start the 2022 IPO Calendar. Two of the week’s three biotech IPOs –  Amylyx Pharmaceuticals (AMLX) and CinCor Pharma (CINC) – upsized their IPOs by adding more shares and pricing their deals at the mid-point of their ranges. The third biotech IPO – Vigil Neuroscience, Inc. (VIGL) – […]

We wish a very Merry Christmas to all of our IPOScoop readers and subscribers who are celebrating! Happy Holidays to all!  No traditional IPOs are confirmed for the pricing schedule next week. It’s likely, though, that a few small-cap IPOs and a steady run of SPACs will be on tap. The IPO market traditionally slows […]

Samsara, Inc. (IOT) priced its long-awaited IPO at $23 – the top of its $20-to-$23 range – and sold 35 million shares on Tuesday night (Dec. 14, 2021). The IPO, dubbed “the deal of the week,” raised $805 million. Samsara’s IPO was the standout on a busy night for IPO bankers, who raised a whopping […]

The “highs” have it. Brazilian digital banking company Nu Holdings (NU) – known as NuBank – priced its IPO on Wednesday night (Dec. 8, 2021) at $9 – the top of its $8-to-$9 range. HashiCorp (HCP), an American cloud software company, priced its long-awaited IPO at $80 – $8 above the top of its $68-to-$72 range. HashiCorp […]